A curcumin-based zinc compound [Zn(II)-curc] also reduced mutant p53 expression in thyroid cancer cells, reactivating p53 tumor suppressor activity and resulting in increased response to anti-cancer therapies [85] (Figure 5). Here, TP53 is linked to thyroid gland carcinoma.